Precise Biometrics AB (publ) (PREC.ST) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-434.1%

-SEK 1.95

vs SEK 0.58 price

Levered DCF

-SEK 2.19

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

0.41

Distress zone

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-9.2×	-44.82×	-2.75×	-8.62×	-43.13×	-42.48×	685.83×	-29×
P/B	1.38×	2.56×	0.45×	1.31×	4.48×	4.46×	5.53×	4.77×
P/S	2.32×	4.45×	0.96×	2.11×	6.88×	5.51×	7.61×	8.85×
EV / EBITDA	57.33×	26.05×	-17.19×	-175.28×	-55.55×	-132.48×	173.66×	-50.21×
Gross margin	72.8%	72.6%	63.7%	71.5%	76.3%	84.2%	86.4%	85.2%
Operating margin	-22.0%	-10.8%	-35.2%	-22.0%	-16.9%	-6.3%	0.7%	-29.5%
Net margin	-25.6%	-9.7%	-35.2%	-24.4%	-16.1%	-13.2%	1.1%	-30.2%
Current ratio	1.37×	1.9×	2.05×	1.57×	1.3×	2.9×	3.4×	3.14×
Debt / equity	0.08×	0.17×	0.03×	0.22×	0.06×	0.06×	0.01×	0×
Interest coverage	-27.96×	-24.39×	-26.46×	-5.86×	-63.11×	-57.35×	1.66×	-997.9×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-15.2%	-5.6%	-16.6%	-15.2%	-10.5%	-10.7%	0.8%	-16.3%
Return on invested capital	-11.6%	-5.3%	-14.6%	-10.9%	-8.3%	-4.8%	0.6%	-15.9%
Return on assets	-11.4%	-4.2%	-12.4%	-10.4%	-5.6%	-8.0%	0.6%	-12.9%
Free cash flow yield	0.4%	-0.3%	-36.2%	-9.3%	-3.7%	0.8%	-0.9%	-6.3%
Earnings yield	-11.0%	-2.2%	-36.6%	-11.6%	-2.3%	-2.4%	0.1%	-3.4%
Enterprise value	SEK 173M	SEK 375M	SEK 29.1M	SEK 178.1M	SEK 516.5M	SEK 439.3M	SEK 626.9M	SEK 519.2M
Net debt / EBITDA	-2.49×	-0.82×	25.39×	13.46×	6.08×	20.95×	-20.11×	7.69×
Cash conversion cycle (days)	62	82	62	-19	-71	-65	-26	-61